CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 65 filers reported holding CASI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $172,000 | -20.4% | 71,591 | -2.3% | 0.00% | – |
| Q4 2020 | $216,000 | +113.9% | 73,286 | +11.5% | 0.00% | – |
| Q3 2020 | $101,000 | -45.4% | 65,753 | -11.2% | 0.00% | – |
| Q2 2020 | $185,000 | +38.1% | 74,030 | +12.9% | 0.00% | – |
| Q1 2020 | $134,000 | -34.0% | 65,555 | 0.0% | 0.00% | – |
| Q4 2019 | $203,000 | -6.9% | 65,555 | +0.3% | 0.00% | – |
| Q3 2019 | $218,000 | +4.8% | 65,387 | +0.4% | 0.00% | – |
| Q2 2019 | $208,000 | +13.7% | 65,125 | +2.2% | 0.00% | – |
| Q1 2019 | $183,000 | -29.3% | 63,753 | -1.0% | 0.00% | -100.0% |
| Q4 2018 | $259,000 | +29.5% | 64,395 | +50.3% | 0.00% | – |
| Q3 2018 | $200,000 | -46.5% | 42,832 | -5.8% | 0.00% | -100.0% |
| Q2 2018 | $374,000 | – | 45,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 951,064 | $7,827,000 | 4.06% |
| Wellington Shields Capital Management, LLC | 855,056 | $7,037,000 | 1.16% |
| Manatuck Hill Partners, LLC | 15,090 | $124,000 | 0.05% |
| Moors & Cabot, Inc. | 22,935 | $187,000 | 0.02% |
| Perceptive Advisors | 43,682 | $360,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 120,000 | $988,000 | 0.01% |
| ALPS ADVISORS INC | 125,015 | $1,029,000 | 0.01% |
| MetLife Investment Management, LLC | 26,316 | $217,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 136,518 | $1,124,000 | 0.00% |
| Private Advisor Group, LLC | 15,001 | $122,000 | 0.00% |